These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


166 related items for PubMed ID: 2680521

  • 1. Investigation of rat striatal dopamine D-1 receptors solubilized by digitonin with a precipitation method.
    Zhang X, Segawa T.
    Eur J Pharmacol; 1989 Aug 03; 166(3):401-10. PubMed ID: 2680521
    [Abstract] [Full Text] [Related]

  • 2. Dopamine D1 receptors characterized with [3H]SCH 23390. Solubilization of a guanine nucleotide-sensitive form of the receptor.
    Niznik HB, Otsuka NY, Dumbrille-Ross A, Grigoriadis D, Tirpak A, Seeman P.
    J Biol Chem; 1986 Jun 25; 261(18):8397-406. PubMed ID: 3522568
    [Abstract] [Full Text] [Related]

  • 3. Solubilization and reconstitution of dopamine D1 receptor from bovine striatal membranes: effects of agonist and antagonist pretreatment.
    Srivastava LK, Ross GM, Bajwa SB, Mishra RK.
    Neurochem Res; 1990 Jun 25; 15(6):647-57. PubMed ID: 1977093
    [Abstract] [Full Text] [Related]

  • 4. Selective blockade of dopamine D-1 receptor by SCH 23390 affects dopamine agonist binding to 3H-spiperone labeled D-2 receptors in rat striatum.
    Zhang X, Segawa T.
    Jpn J Pharmacol; 1989 Jul 25; 50(3):333-45. PubMed ID: 2569545
    [Abstract] [Full Text] [Related]

  • 5. Regulation of agonist and antagonist binding to striatal D-1 dopamine receptors: studies using the selective D-1 antagonist [3H]SK&F R-83566.
    Flaim KE, Gessner GW, Crooke ST, Heys JR, Weinstock J.
    Life Sci; 1986 Jun 09; 38(23):2087-96. PubMed ID: 2872567
    [Abstract] [Full Text] [Related]

  • 6. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
    Thomas KL, Rose S, Jenner P, Marsden CD.
    Biochem Pharmacol; 1992 Jul 07; 44(1):83-91. PubMed ID: 1321631
    [Abstract] [Full Text] [Related]

  • 7. [125I]SCH 23982: the ligand of choice for identifying the D-1 dopamine receptor.
    Sidhu A, van Oene JC, Dandridge P, Kaiser C, Kebabian JW.
    Eur J Pharmacol; 1986 Sep 09; 128(3):213-20. PubMed ID: 2947806
    [Abstract] [Full Text] [Related]

  • 8. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
    Makman MH, Dvorkin B.
    Brain Res; 1986 Dec 09; 387(3):261-70. PubMed ID: 2950967
    [Abstract] [Full Text] [Related]

  • 9. Binding of [3H]SKF 38393 to dopamine D-1 receptors in rat striatum in vitro; estimation of receptor molecular size by radiation inactivation.
    Gredal O, Nielsen M.
    J Neurochem; 1987 Feb 09; 48(2):370-5. PubMed ID: 3491877
    [Abstract] [Full Text] [Related]

  • 10. Properties of rat striatal D-2 dopamine receptors solubilized with the zwitterionic detergent CHAPS.
    Kilpatrick GJ, Jenner P, Marsden CD.
    J Pharm Pharmacol; 1985 May 09; 37(5):320-8. PubMed ID: 2862240
    [Abstract] [Full Text] [Related]

  • 11. Target size of dopamine D-1 receptors in rat corpus striatum estimated by binding of the benzazepine 3H-SCH 23390.
    Gredal O, Nielsen M, Hyttel J.
    Pharmacol Toxicol; 1987 Apr 09; 60(4):255-7. PubMed ID: 2954035
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. SCH 23390 blocks D-1 and D-2 dopamine receptors in rat neostriatum in vitro.
    Plantjé JF, Daus FJ, Hansen HA, Stoof JC.
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep 09; 327(2):180-2. PubMed ID: 6208489
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological and biochemical characterization of dopamine receptors mediating stimulation of a high affinity GTPase in rat striatum.
    Onali P, Olianas MC.
    Biochem Pharmacol; 1987 Sep 01; 36(17):2839-45. PubMed ID: 2820423
    [Abstract] [Full Text] [Related]

  • 15. Pharmacology of binding of 3H-SCH-23390 to D-1 dopaminergic receptor sites in rat striatal tissue.
    Faedda G, Kula NS, Baldessarini RJ.
    Biochem Pharmacol; 1989 Feb 01; 38(3):473-80. PubMed ID: 2563653
    [Abstract] [Full Text] [Related]

  • 16. Structural determinants of selective affinity for brain D-1 dopamine receptors within a series of 1-phenyl-1H-3-benzazepine analogues of SK&F 38393 and SCH 23390.
    O'Boyle KM, Waddington JL.
    Eur J Pharmacol; 1985 Sep 24; 115(2-3):291-5. PubMed ID: 2866103
    [Abstract] [Full Text] [Related]

  • 17. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone.
    Protais P, Lesourd M, Comoy E.
    Eur J Pharmacol; 1998 Jul 10; 352(2-3):179-87. PubMed ID: 9716353
    [Abstract] [Full Text] [Related]

  • 18. Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation.
    Thomas KL, Rose S, Jenner P, Marsden CD.
    Biochem Pharmacol; 1992 Jul 07; 44(1):73-82. PubMed ID: 1321630
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and dopamine receptor affinities of 6-amino-5,6,7,8-tetrahydroquinoline derivatives.
    Claudi F, Cingolani GM, Giorgioni G, Cattabeni F, Cimino M, Di Luca M.
    Drug Des Deliv; 1989 Jun 07; 4(4):279-87. PubMed ID: 2570592
    [Abstract] [Full Text] [Related]

  • 20. Preparation of an affinity chromatography matrix for the selective purification of the dopamine D2 receptor from bovine striatal membranes.
    Clagett-Dame M, Schoenleber R, Chung C, McKelvy JF.
    Biochim Biophys Acta; 1989 Nov 27; 986(2):271-80. PubMed ID: 2531613
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.